Mixed Topics
Feature
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate Markers
As the FDA’s use of surrogate endpoints in the drug approval process is increasing, researchers are concerned important postapproval or validation...
News from the FDA/CDC
FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung Cancer
Approval was based on data from 99 patients in the DeLLphi-301 trial with relapsed/refractory extensive-stage SCLC who had progressed after...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
From the Journals
Hypofractionated Radiotherapy Limits Toxic Effects in Cervical Cancer
Researchers analyze outcomes from patients undergoing hypofractionated IMRT for cervical cancer after radical hysterectomy and pelvic lymph node...
Conference Coverage
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies
Survey respondents classify and grade morbilliform, psoriasiform, and papulopustular rashes based on a review of photographs and text descriptions...
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
From the Journals
Can a Risk Score Predict Kidney Injury After Cisplatin?
Researchers have developed a risk algorithm to predict acute kidney injury after cisplatin administration and tested it using data from six US...
From the Journals
Do Patients Benefit from Cancer Trial Participation?
Researchers conduct a meta-analysis comprising 141 comparisons of an investigational drug and a control treatment, which include immunotherapies...
Feature
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?
Researchers examine links between mortality risk and health-related social needs in patients who had cancer.
From the Journals
Terminal Cancer: What Matters to Patients and Caregivers
Patients and caregivers are less aligned on decisions about cost containment than end-of-life goals.
Feature
The Long, Controversial Search for a ‘Cancer Microbiome’
Research raised as many questions as answers about what we do and don’t know about microbiota and cancer.